Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer’s disease

Human Brain Mapping

Volumn 38, Issue 4, 2017, Pages 1933-1940

  Mullins, Roger J ^a   Mustapic, Maja ^a   Goetz, Edward J ^b   Kapogiannis, Dimitrios ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer s disease; Biomarker; Exosomes; Insulin resistance; IRS 1; Magnetic resonance imaging

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; INSULIN RECEPTOR SUBSTRATE 1; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN; NERVE CELL ADHESION MOLECULE L1; PEPTIDE FRAGMENT; SERINE; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; BRAIN TISSUE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DEMENTIA; EXOSOME; FEMALE; GRAY MATTER; HUMAN; IMMUNOPRECIPITATION; INSULIN RESISTANCE; MALE; MIDDLE TEMPORAL GYRUS; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETO-OCCIPITAL SULCUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEIN ISOLATION; VOXEL BASED MORPHOMETRY; ATROPHY; BRAIN; COMPLICATION; DIAGNOSTIC IMAGING; IMAGE PROCESSING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ATROPHY; BRAIN; EXOSOMES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOPRECIPITATION; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; NEURAL CELL ADHESION MOLECULE L1; PEPTIDE FRAGMENTS; PHOSPHORYLATION; SERINE; TAU PROTEINS;

EID: 85010750365     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.23494     Document Type: Article

References (48)

1. Albert, MS, DeKosky, ST, Dickson, D, Dubois, B, Feldman, HH, Fox, NC, Gamst, A, Holtzman, DM, Jagust, WJ, Petersen, RC, Snyder, PJ, Carrillo, MC, Thies, B, Phelps, CH (2011): The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging- Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279.
2. Ashburner J, Friston KJ (2000): Voxel-based morphometry–The methods. Neuroimage 11:805–821.
3. Ashburner J, Friston KJ (2005): Unified segmentation. Neuroimage 26:839–851.
4. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S (2011): Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68:51–57.
5. Bomfim, TR, Forny-Germano, L, Sathler, LB, Brito-Moreira, J, Houzel, JC, Decker, H, Silverman, MA, Kazi, H, Melo, HM, McClean, PL, Holscher, C, Arnold, SE, Talbot, K, Klein, WL, Munoz, DP, Ferreira, ST, De Felice, FG (2012): An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Abeta oligomers. J Clin Invest 122:1339–1353.
6. Caccamo A, Magri A, Medina DX, Wisely EV, Lopez-Aranda MF, Silva AJ, Oddo S (2013): mTOR regulates tau phosphorylation and degradation: Implications for Alzheimer’s disease and other tauopathies. Aging Cell 12:370–380.
7. Choeiri C, Staines W, Messier C (2002): Immunohistochemical localization and quantification of glucose transporters in the mouse brain. Neuroscience 111:19–34.
8. Chua LM, Lim ML, Chong PR, Hu ZP, Cheung NS, Wong BS (2012): Impaired neuronal insulin signaling precedes Abeta42 accumulation in female AbetaPPsw/PS1DeltaE9 mice. J Alzheimers Dis 29:783–791.
9. Copps KD, White MF (2012): Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55:2565–2582.
10. Craft S (2012): Alzheimer disease: Insulin resistance and AD–extending the translational path. Nat Rev Neurol 8: 360–362.
11. Crane, PK, Walker, R, Hubbard, RA, Li, G, Nathan, DM, Zheng, H, Haneuse, S, Craft, S, Montine, TJ, Kahn, SE, McCormick, W, McCurry, SM, Bowen, JD, Larson, EB (2013): Glucose levels and risk of dementia. N Engl J Med 369:540–548.
12. De Felice FG, Ferreira ST (2014): Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes 63:2262–2272.
13. de la Monte SM (2009): Insulin resistance and Alzheimer’s disease. BMB Rep 42:475–481.
14. de la Monte SM (2012): Therapeutic targets of brain insulin resistance in sporadic Alzheimer’s disease. Front Biosci (Elite Ed) 4: 1582–1605.
15. Fiandaca, MS, Kapogiannis, D, Mapstone, M, Boxer, A, Eitan, E, Schwartz, JB, Abner, EL, Petersen, RC, Federoff, HJ, Miller, BL, Goetzl, EJ (2015): Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement 11: 600–607, e1.
16. Goetzl, EJ, Boxer, A, Schwartz, JB, Abner, EL, Petersen, RC, Miller, BL, Carlson, OD, Mustapic, M, Kapogiannis, D (2015a): Low neural exosomal levels of cellular survival factors in Alzheimer’s disease. Ann Clin Transl Neurol 2:769–773.
17. Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D (2015b): Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 85:40–47.
18. Gorgolewski, KJ, Fox, AS, Chang, L, Schafter, A, Arelin, K, Burmann, I, Sacher, J, Margulies, AD (2014): Tight Fitting Genes: Finding Relations Between Statistical Maps and Gene Expression Patterns. F1000Posters 2014, 5:1607 (poster). Retrieved from: https://f1000research.com/posters/1097120.
19. Gray SM, Meijer RI, Barrett EJ (2014): Insulin regulates brain function, but how does it get there? Diabetes 63:3992–3997.
20. Grillo CA, Piroli GG, Hendry RM, Reagan LP (2009): Insulinstimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res 1296: 35–45.
21. Gual P, Le Marchand-Brustel Y, Tanti JF (2005): Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87:99–109.
22. Hawrylycz, MJ, Lein, ES, Guillozet-Bongaarts, AL, Shen, EH, Ng, L, Miller, JA, van de Lagemaat, LN, Smith, KA, Ebbert, A, Riley, ZL, Abajian, C, Beckmann, CF, Bernard, A, Bertagnolli, D, Boe, AF, Cartagena, PM, Chakravarty, MM, Chapin, M, Chong, J, Dalley, RA, Daly, BD, Dang, C, Datta, S, Dee, N, Dolbeare, TA, Faber, V, Feng, D, Fowler, DR, Goldy, J, Gregor, BW, Haradon, Z, Haynor, DR, Hohmann, JG, Horvath, S, Howard, RE, Jeromin, A, Jochim, JM, Kinnunen, M, Lau, C, Lazarz, ET, Lee, C, Lemon, TA, Li, L, Li, Y, Morris, JA, Overly, CC, Parker, PD, Parry, SE, Reding, M, Royall, JJ, Schulkin, J, Sequeira, PA, Slaughterbeck, CR, Smith, SC, Sodt, AJ, Sunkin, SM, Swanson, BE, Vawter, MP, Williams, D, Wohnoutka, P, Zielke, HR, Geschwind, DH, Hof, PR, Smith, SM, Koch, C, Grant, SG, Jones, AR (2012): An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489: 391–399.
23. Hoehn, KL, Hohnen-Behrens, C, Cederberg, A, Wu, LE, Turner, N, Yuasa, T, Ebina, Y, James, DE (2008): IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7: 421–433.
24. Kapogiannis, D, Boxer, A, Schwartz, JB, Abner, EL, Biragyn, A, Masharani, U, Frassetto, L, Petersen, RC, Miller, BL, Goetzl, EJ (2015): Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer’s disease. FASEB J 29:589–596.
25. Keeney JT, Ibrahimi S, Zhao L (2015): Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: Evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer’s disease prevention and early intervention. J Alzheimers Dis 48:411–424.
26. Ma, QL, Yang, F, Rosario, ER, Ubeda, OJ, Beech, W, Gant, DJ, Chen, PP, Hudspeth, B, Chen, C, Zhao, Y, Vinters, HV, Frautschy, SA, Cole, GM (2009): B amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29:9078–9089.
27. Mamelak M (2012): Sporadic Alzheimer’s disease: The starving brain. J Alzheimers Dis 31:459–474.
28. McEwen BS, Reagan LP (2004): Glucose transporter expression in the central nervous system: Relationship to synaptic function. Eur J Pharmacol 490:13–24.
29. McKhann, GM, Knopman, DS, Chertkow, H, Hyman, BT, Jack, CR, Jr., Kawas, CH, Klunk, WE, Koroshetz, WJ, Manly, JJ, Mayeux, R, Mohs, RC, Morris, JC, Rossor, MN, Scheltens, P, Carrillo, MC, Thies, B, Weintraub, S, Phelps, CH (2011): The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269.
30. Orr ME, Salinas A, Buffenstein R, Oddo S (2014): Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer’s disease pathology. Neurobiol Aging 35:1233–1242.
31. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM (1999): Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53:1937–1942.
32. Pearson-Leary J, McNay EC (2012): Intrahippocampal administration of amyloid-beta(1-42) oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism. J Alzheimers Dis 30:413–422.
33. Pederson TM, Kramer DL, Rondinone CM (2001): Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes 50: 24–31.
34. Penny W, Holmes AP (2004): Chapter 42 – Random-Effects Analysis. In: Human Brain Function, 2nd ed. Burlington: Academic Press. pp 843–850.
35. Pini, L, Pievani, M, Bocchetta, M, Altomare, D, Bosco, P, Cavedo, E, Galluzzi, S, Marizzoni, M, Frisoni, GB (2016): Brain atrophy in Alzheimer’s Disease and aging. Ageing Res Rev.
36. Sankar R, Thamotharan S, Shin D, Moley KH, Devaskar SU (2002): Insulin-responsive glucose transporters-GLUT8 and GLUT4 are expressed in the developing mammalian brain. Brain Res Mol Brain Res 107:157–165.
37. Schmid RS, Maness PF (2008): L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol 18:245–250.
38. Schrijvers EM, Witteman JC, Sijbrands EJ, Hofman A, Koudstaal PJ, Breteler MM (2010): Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study. Neurology 75: 1982–1987.
39. Sun XJ, Goldberg JL, Qiao LY, Mitchell JJ (1999): Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48:1359–1364.
40. Talbot K, Wang HY (2014): The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer’s disease. Alzheimers Dement 10:S12–S25.
41. Talbot, K, Wang, HY, Kazi, H, Han, LY, Bakshi, KP, Stucky, A, Fuino, RL, Kawaguchi, KR, Samoyedny, AJ, Wilson, RS, Arvanitakis, Z, Schneider, JA, Wolf, BA, Bennett, DA, Trojanowski, JQ, Arnold, SE (2012): Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316–1338.
42. Taniguchi CM, Emanuelli B, Kahn CR (2006): Critical nodes in signalling pathways: Insights into insulin action. Nat Rev Mol Cell Biol 7:85–96.
43. Wang, WY, Yu, JT, Liu, Y, Yin, RH, Wang, HF, Wang, J, Tan, L, Radua, J, Tan, L (2015): Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease. Transl Neurodegener 4:6.
44. Willette, AA, Bendlin, BB, Starks, EJ, Birdsill, AC, Johnson, SC, Christian, BT, Okonkwo, OC, La Rue, A, Hermann, BP, Koscik, RL, Jonaitis, EM, Sager, MA, Asthana, S (2015a): Association of insulin resistance with cerebral glucose uptake in latemiddle-aged adults at risk for Alzheimer disease. JAMA Neurol 72:1013–1020.
45. Willette, AA, Johnson, SC, Birdsill, AC, Sager, MA, Christian, B, Baker, LD, Craft, S, Oh, J, Statz, E, Hermann, BP, Jonaitis, EM, Koscik, RL, La Rue, A, Asthana, S, Bendlin, BB (2015b): Insulin resistance predicts brain amyloid deposition in late middleaged adults. Alzheimers Dement 11:504–510, e1.
46. Willette AA, Modanlo N, Kapogiannis D, Alzheimer’s Disease Neuroimaging Initiative (2015c): Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease. Diabetes 64:1933–1940.
47. Willette, AA, Xu, G, Johnson, SC, Birdsill, AC, Jonaitis, EM, Sager, MA, Hermann, BP, La Rue, A, Asthana, S, Bendlin, BB (2013): Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care 36:443–449.
48. Woo CW, Krishnan A, Wager TD (2014): Cluster-extent based thresholding in fMRI analyses: Pitfalls and recommendations. Neuroimage 91:412–419.